Blockade of p53 and Aurora A in Therapy Resistant Neuroblastoma |
University of California San Francisco / William Clay Gustafson, MD, PhD |
'A' Award Grants |
2011 |
California |
WWOX as a Signal Mediator in Pediatric Osteosarcoma |
The Ohio State University / Rami Aqeilan |
'A' Award Grants |
2009 |
Ohio |
BET Bromodomain Inhibition as Epigenetic Therapy in Pediatric Leukemia |
Cold Spring Harbor Laboratory / Christopher Vakoc, MD, PhD |
'A' Award Grants |
2012 |
New York |
Investigating the Role of Genetic and Epigenetic Variation in Risk of Childhood Acute Lymphoblastic Leukemia in Down Syndrome |
University of California San Francisco / Adam de Smith, Ph.D. |
'A' Award Grants |
2014 |
California |
Uncovering the Dysregulated RNA Binding Protein Network in Childhood Acute Myeloid Leukemia |
Memorial Sloan-Kettering Cancer Center / Michael Kharas, PhD |
'A' Award Grants |
2016 |
New York |
Targeting Metabolism in Alveolar Soft Part Sarcomagenesis |
Huntsman Cancer Institute / Kevin Jones, MD |
'A' Award Grants |
2013 |
Utah |
A Combinatorial Approach to Target the Tumor-Initiating and Transit Amplifying Cellular Subpopulations in Diffuse Intrinsic Pontine Glioma (DIPG) |
Stanford University / Michelle Monje, MD, PhD |
'A' Award Grants |
2011 |
California |
DNA Damage Responses Coordinate Survival and Cell Death Switching In Lymphocytes |
Washington University / Jeffrey Bednarski, MD, PhD |
'A' Award Grants |
2013 |
Missouri |
Elucidating the Role of SETD2 in Pediatric High Grade Glioma Formation |
Children’s Hospital of Philadelphia / Thomas De Raedt, PhD |
'A' Award Grants |
2019 |
Pennsylvania |
Reversing mSWI/SNF (BAF) Complex Misassembly and Genomic Targeting in Human Synovial Sarcoma |
Dana-Farber Cancer Institute / Cigall Kadoch, PhD |
'A' Award Grants |
2017 |
Massachusetts |